This inventor holds 13 USPTO granted patents and 3 published patent applications and 7 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Millennium Pharmaceuticals Limited, Cubist Pharmaceuticals, Incorporated. Active years: 2011-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Skillman, NJ (US) (2011)
- Lansdale, PA (US) (2013 - 2018)
Company Filing History:
6 out of 2,405 
6 out of 854 
1 out of 59 
Years Active: 2011-2018
Title: Innovator Spotlight: Jing Li – A Pioneer in Novel Therapeutics
Introduction: Jing Li, based in Lansdale, PA, is a distinguished inventor with a remarkable portfolio of 13 patents. Her groundbreaking work focuses on developing novel compounds that serve as proteasome inhibitors and advanced imaging agents for neurodegenerative diseases. Her contributions to the field of pharmaceuticals have positioned her as a key figure in modern medicinal research.
Latest Patents: Among her most recent innovations is the patent for "Derivatives of 1-amino-2-cyclobutylethylboronic acid," which presents novel compounds that can be used as proteasome inhibitors. This invention also includes pharmaceutical compositions that incorporate these compounds, offering promising methods for treating various diseases. Another significant patent is for "Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrillary tangles." This invention provides pyrrolopyridine compounds suitable for imaging tau aggregates relevant to Alzheimer's patients. Specifically, it details a method of using these compounds as tracers in positron emission tomography (PET) imaging, enabling in vivo study of tau deposits in the brain to facilitate the diagnosis of Alzheimer's and other neurodegenerative conditions.
Career Highlights: Jing Li has notably worked with prestigious companies such as Merck Sharp & Dohme Corporation and Millennium Pharmaceuticals Limited. Her time at these organizations provided her with the experience and resources needed to innovate and advance her research in pharmaceuticals.
Collaborations: In her career, Jing has collaborated with esteemed colleagues, including Paul E. Fleming and Jianmin Fu. These collaborations have played a vital role in her research, contributing to the successful development of her patented inventions.
Conclusion: Jing Li's contributions to the fields of drug development and diagnostic imaging showcase her dedication to improving therapeutic options for complex diseases. Her innovative inventions and collaborations with other experts highlight her influence in the pharmaceutical industry, inspiring future generations of inventors in the realm of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile